Education
About Us
Working with TipRanks
Follow Us
FSML - ETF AI Analysis
Top Page
Franklin Small Cap Enhanced ETF (FSML)
Rating:66Neutral
Price Target:―
Positive Factors
Broad Sector Diversification
The ETF spreads its investments across many sectors, which can help reduce the impact if any one industry runs into trouble.
Generally Strong Top Holdings
Most of the largest positions have shown strong or steady performance so far this year, supporting the fund’s overall returns.
Positive Recent Performance
The fund has delivered solid gains both year-to-date and over the past month, indicating recent momentum in its small-cap strategy.
Negative Factors
High U.S. Concentration
With almost all assets in U.S. stocks, the ETF offers very little geographic diversification and is heavily tied to the U.S. market.
Moderate Expense Ratio
The fund’s fee is not especially low for an ETF, which can slightly reduce long-term returns compared with cheaper options.
Some Weak Top Holdings
A few of the largest positions have shown weak or negative performance this year, which can drag on the fund if those stocks do not recover.
FSML vs. SPDR S&P 500 ETF (SPY)
AUM99.71M
RegionNorth America
Expense Ratio0.45%
Beta1.17
IssuerFranklin
Inception DateDec 09, 2025
Dividend Yield0.06%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,416
30 Day Avg. Volume107,702
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
30.96Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering298
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FSML Summary
The Franklin Small Cap Enhanced ETF (FSML) is an actively managed fund that focuses on smaller U.S. companies, rather than tracking a set index. It uses a rules-based approach to pick promising small-cap stocks across many sectors, including financials, health care, and technology. Well-known names in the fund include Jackson Financial and Commercial Metals Company. Someone might invest in FSML to seek long-term growth and to diversify beyond large, familiar companies. However, small-cap stocks can be more volatile, so the ETF’s price can move up and down more sharply than the overall market.
How much will it cost me?This ETF has an annual expense ratio of 0.45%, which means you’ll pay about $4.50 per year for every $1,000 you invest. That’s higher than the cost of many index (passive) ETFs because this fund is actively managed, using a more involved strategy to pick small-cap stocks.
What would affect this ETF?This U.S. small-cap ETF could benefit if the economy stays healthy, interest rates stabilize or fall, and innovation in areas like financials, health care, and industrials supports faster growth for smaller companies. On the other hand, a recession, higher borrowing costs, or tighter regulations on banks, insurers, and health care firms could hurt many of its holdings and make small-cap stocks more volatile and vulnerable than larger, more established companies.
FSML Top 10 Holdings
FSML is leaning into U.S. small caps with a noticeable tilt toward financials and industrials, and that mix is largely paying off. Commercial Metals, Primoris Services, and Boise Cascade have been rising, giving the fund a solid industrial backbone, while Atmus Filtration and Avient add steady support from the materials and manufacturing side. Guardant Health has been a high‑beta bright spot, surging recently but adding some volatility. On the flip side, Essent Group and CNO Financial are losing steam, keeping the financial sleeve from fully hitting its stride.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Valaris | 1.56% | $1.59M | $6.15B | 99.71% | 76 Outperform | |
| Bloom Energy | 1.49% | $1.51M | $39.00B | 447.15% | 62 Neutral | |
| Primoris Services | 1.39% | $1.41M | $8.83B | 122.32% | 75 Outperform | |
| Commercial Metals Company | 1.38% | $1.40M | $8.85B | 51.92% | 70 Neutral | |
| Guardant Health | 1.37% | $1.39M | $13.29B | 113.55% | 61 Neutral | |
| Kulicke & Soffa | 1.34% | $1.37M | $3.77B | 75.50% | 61 Neutral | |
| BridgeBio Pharma | 1.32% | $1.34M | $14.66B | 117.94% | 59 Neutral | |
| Valley National Bancorp | 1.31% | $1.33M | $7.42B | 33.53% | 73 Outperform | |
| UFP Industries | 1.28% | $1.30M | $6.67B | -1.63% | 68 Neutral | |
| Proto Labs | 1.26% | $1.28M | $1.57B | 50.41% | 70 Outperform |
FSML Technical Analysis
Negative
―
Price Trends
Market Momentum
0.28
Positive
50.82
Neutral
68.44
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSML, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 26.33, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.28 indicates Positive momentum. The RSI at 50.82 is Neutral, neither overbought nor oversold. The STOCH value of 68.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FSML.
FSML Peer Comparison
Comparison Results
Performance Comparison
FSML
Franklin Small Cap Enhanced ETF
26.23
0.99
3.92%
OSCV
Opus Small Cap Value ETF
―
―
―
SEIS
SEI Select Small Cap ETF
―
―
―
FSCC
Federated Hermes MDT Small Cap Core ETF
―
―
―
SCDV
Bahl & Gaynor Small Cap Dividend ETF
―
―
―
SIXS
ETC 6 Meridian Small Cap Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents